Effects of a phone-based, CBT-I–centered digital intervention on sleep and depressive symptoms in real-world clinical settings
Open Access
- 29 April 2026
- journal article
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
Abstract
This study aimed to investigate Item s associated with treatment response to a phone-based, CBT-I-centered digital intervention in patients with depressive disorders, with a primary focus on sleep-related improvement and its association with changes in depressive symptoms. A total of 307 outpatients with depressive disorders were enrolled from a sleep disorders clinic and received a phone-based, CBT-I-centered digital intervention delivered via a mobile application, in addition to routine pharmacotherapy. The intervention primarily targeted sleep disturbances and incorporated CBT techniques and psychoeducation. Participants completed demographic questionnaires and were assessed using the Pittsburgh Sleep Quality Index (PSQI), Patient Health Questionnaire-9(PHQ-9), Patient Health Questionnaire-15 (PHQ-15), and Epworth Sleepiness Scale (ESS).Treatment response was defined as a ≥ 50% reduction in total PHQ-9 score. Item s influencing treatment response at weeks 8 and 12, as well as Item s associated with residual symptoms at week 12, were analyzed. Univariate analyses showed that age and education level were significantly associated with treatment response at both weeks 8 and 12 (P < 0.05), whereas gender was not. Multivariate logistic regression indicated that younger age (< 30 years) and longer disease duration (> 3 years) were independently associated with poorer treatment outcomes at both follow-up points.At week 12, residual symptoms were significantly associated with younger age, longer disease duration, poorer sleep quality (higher PSQI scores), greater somatic symptom burden (PHQ-15), and increased daytime sleepiness (ESS).Multivariate analyses identified younger age, longer disease duration, and family history of depression as independent risk Item s for residual symptoms. This real-world study suggests that a CBT-I-centered digital intervention primarily targeting sleep disturbances may be associated with concurrent improvements in depressive symptoms among patients with depression. Younger patients and those with longer illness duration appear to be at higher risk for poorer outcomes and persistent residual symptoms. ChiCTR2500103629.Keywords
Funding Information
- Hangzhou Pharmaceutical and Health Science and Technology Project (A20210156)
- 2025 Annual "Pioneer & Leader + X" Science and Technology Plan Projects of Zhejiang Provincial Department of Science and Technology (2025C01103)
This publication has 35 references indexed in Scilit:
- Reducing the global burden of depression: a Lancet–World Psychiatric Association CommissionThe Lancet, 2019
- Prospective predictors of first-onset depressive disorders in adolescent females with anxiety disordersJournal of Affective Disorders, 2018
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysisThe Lancet, 2018
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2017
- Evaluation of the measurement properties of the Epworth sleepiness scale: A systematic reviewSleep Medicine Reviews, 2014
- Depression and cancer mortality: a meta-analysisPsychological Medicine, 2010
- Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D reportPsychological Medicine, 2009
- The human emotional brain without sleep — a prefrontal amygdala disconnectCurrent Biology, 2007
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- The empirical status of cognitive-behavioral therapy: A review of meta-analysesClinical Psychology Review, 2006